Alibaba-Backed Robotics Firm LimX Plans Hong Kong IPO, Seeking Up to $300 Million
Nashnova编辑部
Shenzhen-based humanoid-robot maker LimX Dynamics has confidentially filed for a Hong Kong IPO, seeking up to $300 million at a roughly $2.2 billion valuation — the largest deal yet in a wave of Chinese robotics listings.
What do we know about the deal?
LimX Dynamics has confidentially filed its listing application with the Hong Kong Stock Exchange, with CITIC Securities as underwriter.
The company is targeting up to $300 million in proceeds, though deal size and timing are still being negotiated.
CFO Jesse Liu confirmed the IPO push in a Bloomberg TV interview on Monday but gave no further details.
What does LimX actually do, and what is it worth?
Founded in 2022, LimX develops humanoid robots for homes, factories, labs, and commercial spaces.
Its shareholder roster includes Alibaba, JD.com, and IDG Capital — three top-tier investors backing the same thesis signals strong sector consensus.
In July this year, LimX closed a pre-IPO round — the last private fundraise before listing — raising $200 million at a valuation of roughly RMB 15 billion (about $2.2 billion).
Why are robot companies all rushing to list in Hong Kong?
LimX is not alone — Robotera, Linkerbot, and BYD-backed PaXini are all preparing Hong Kong IPOs.
Unitree Robotics listed on Shanghai's STAR Market on August 19, becoming China's first publicly traded humanoid-robot company, raising roughly RMB 6.1 billion.
This means → the entire sector is shifting from private fundraising to public-market pricing, with robotics firms collectively sprinting toward capitalization.
How hot is Hong Kong's IPO window right now?
Hong Kong's IPO proceeds this year have already topped $42 billion. HKEX CEO Bonnie Chan says the city is heading for a record listing year.
A cluster of AI-related listings is the main driver.
In plain terms = the window is open, but whether LimX can price smoothly hinges on Unitree's post-listing stock performance — if Unitree trades well, it anchors valuations for the whole sector; if it stumbles, every company in the queue will need to renegotiate.
Content is for reference only, not financial advice.